Phase III trial of imeglimin in patients with type 2 diabetes mellitus
Phase of Trial: Phase III
Latest Information Update: 12 Sep 2016
At a glance
- Drugs Imeglimin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Poxel
- 12 Sep 2016 According to a company media release, Poxel expects to initiate this trial during the fourth quarter of 2017.
- 30 Jun 2016 According to a company media release, Poxel expects to initiate this trial during the second half of 2017.
- 01 Apr 2016 According to Poxel media release, this trial will support future regulatory submissions in the US and Japan.